Analyzing Panagora Asset Management's Q3-Q4 2022 Holdings: Winners, Losers, and Surprises

Investors are always on the lookout for new opportunities to invest their money and make a profit. This is why 13F filings are eagerly anticipated. A 13F filing is a quarterly report filed by institutional investment managers with the Securities and Exchange Commission (SEC) that discloses their equity holdings. Panagora Asset Management is one such firm that has filed its Q3 and Q4 2022 13F holdings with the SEC. In this blog post, we will analyze their holdings in detail, highlighting the winners, losers, and surprises.

The Winners:

Microsoft Corporation (MSFT) and Exxon Mobil Corporation (XOM) were among the top winners. Panagora Asset Management increased its holdings of MSFT in Q4 2022, adding 292,115 shares to reach 2,831,758 shares. Meanwhile, their holdings of XOM also increased from 1,877,730 shares to 2,007,812 shares. This netted the firm a gain of 35.1% in value. It is worth noting that both stocks have been performing well in the market, with MSFT up by 97.9% and XOM up by 46.6% over the past year.

The Losers:

Amazon.com, Inc. (AMZN) and Tesla, Inc. (TSLA) were among the top losers. Panagora Asset Management significantly reduced its holdings of AMZN in Q4 2022, selling 321,296 shares and reducing its total ownership to 2,892,671 shares. This resulted in a decline of 33.1% in value. Similarly, the firm reduced its TSLA holdings by 4,948 shares, resulting in a decline of 53.8% in value. While AMZN has been struggling in the market, TSLA has been inconsistent with its performance over the past year.

The Surprises:

Comcast Corporation (CMCSA) was the biggest surprise. Panagora Asset Management dramatically increased its holdings of this stock, adding 1,760,959 shares to its portfolio, which now totals 2,557,045 shares – an incredible gain of 282.5% in value. This is quite impressive, given that CMCSA has been a laggard in the market, up by only 0.83% over the past year.

Other stocks that caught our attention were Bristol-Myers Squibb Co. (BMY) and MetLife Inc. (MET). Panagora Asset Management increased its BMY holdings by 2.6% while decreasing its MET holdings by 17.3%. This is despite both stocks performing relatively well in the market, with BMY up by 52.9% and MET up by 18.2% over the past year.

Conclusion:

In conclusion, it is apparent that Panagora Asset Management's holdings underwent significant changes between Q3 and Q4 2022. While the firm was able to make gains on stocks like MSFT and XOM, it also experienced declines on stocks like AMZN and TSLA. Their decision to buy into CMCSA was quite surprising but has ultimately paid off. As always, investors should carefully analyze fund holdings to make informed investment decisions.